Literature DB >> 8151109

Dextropropoxyphene induced hepatotoxicity: a report of nine cases.

W M Rosenberg1, N G Ryley, J M Trowell, J O McGee, R W Chapman.   

Abstract

Nine patients are described with jaundice, upper abdominal pain and malaise attributable to dextropropoxyphene hepatotoxicity. In each case the history was suggestive of large bile duct obstruction. All patients underwent ultrasound examination and percutaneous liver biopsy. Three patients also underwent endoscopic retrograde cholangio pancreatography. The histological features of the biopsies concur with previously reported cases of dextropropoxyphene hepatotoxicity. The histological changes seen on biopsy were remarkably constant, consisting of centrilobular cholestasis, portal tract inflammation and bile duct abnormalities, in all cases mimicking large bile duct obstruction. Fifteen previous patients with probable dextropropoxyphene hepatotoxicity have been described. The occurrence of 9 further cases at one centre, 6 presenting within 12 months, suggests that it is much more common than previously assumed and may be misdiagnosed as large bile duct obstruction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8151109     DOI: 10.1016/s0168-8278(05)80560-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

Review 1.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Fatal cholestatic liver failure associated with gemcitabine therapy.

Authors:  Keith Robinson; Louis Lambiase; Jianjun Li; Carmela Monteiro; Michael Schiff
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

Review 3.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

Review 4.  Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.

Authors:  Mellar Davis
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 5.  Opioid Drugs in Patients With Liver Disease: A Systematic Review.

Authors:  Hassan Soleimanpour; Saeid Safari; Kavous Shahsavari Nia; Sarvin Sanaie; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-03-06       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.